Walgreens confirmed Tuesday a new round of layoffs, the latest in a string of job cuts over the past year as the retail pharmacy giant aims to slash costs.
Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical interests have rattled the biotech industry.
The decision to drop the deal came after U.S. District Judge Brian Martinotti refused to certify a class in the litigation, which also targets insulin drug makers Novo Nordisk and Sanofi.